{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:38:01Z","timestamp":1783723081522,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Malaria vaccination was piloted in selected areas of three countries to produce evidence that would inform global recommendations on the public health use of the RTS,S\/AS01\n                      <jats:sub>E<\/jats:sub>\n                      (RTS,S) malaria vaccine and to inform guidance for countries planning to introduce the vaccine into childhood immunization systems. This paper focuses on challenges to the uptake and delivery of a four-dose RTS,S schedule, presents actionable insights into qualitative data from the 2019\u20132023 Malaria Vaccine Pilot Evaluation in Ghana, Kenya, and Malawi, and presents recommendations to address barriers to vaccine uptake.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This paper draws on published qualitative data from the three pilot countries and unpublished expert analysis. It draws on findings previously reported in publications from a qualitative longitudinal study, the Healthcare Utilization Study (HUS), conducted in a subsample of communities where RTS,S was introduced during the pilots. The study elicited perceptions from caregivers of eligible children about the vaccine alongside other relevant topics, such as their use of vaccination services. Interviews with health workers focused on their evolving perceptions about the vaccine and experiences integrating its delivery into routine immunization. Technical experts involved in the vaccine pilot and implementation managers from the pilot countries provided insights from their experiences. This feedback helped validate both the findings and the potential practicality of recommendations for scaling up delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Despite good acceptance of the vaccine, many children missed some or all doses due to overlapping challenges to acceptance and delivery of the four-dose schedule. Highlighting the barriers to uptake, the paper discusses guidance, tools, and materials that may help programme staff develop strategies, plans, and materials, including strategies to address the complexity of the schedule and to track four doses for individual children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adding a four-dose vaccine to a crowded routine immunization schedule presents challenges, as seen during the pilots. The malaria vaccine experience and several studies have provided guidance and tools to support malaria vaccine expansion in the three countries and introduction of the vaccine elsewhere. The observations and recommendations in this paper are intended as a complement to the wide range of materials, guidance and tools already available.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-025-05611-3","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:18:34Z","timestamp":1763464714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recommendations to mitigate barriers to uptake and delivery of a four-dose malaria vaccine schedule: insights from the MVIP\u2019s qualitative evidence"],"prefix":"10.1186","volume":"24","author":[{"given":"Jessica","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Collymore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Tanko","family":"Bawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouden Esau","family":"Mkisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayenne","family":"Buell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose E.","family":"Jalang\u2019o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Chisema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwame","family":"Amponsa-Achiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Scott","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"5611_CR1","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1016\/j.vaccine.2016.10.047","volume":"36","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Malaria vaccine: WHO position paper, January 2016 - recommendations. Vaccine. 2018;36:3576\u20137.","journal-title":"Vaccine"},{"issue":"9","key":"5611_CR2","first-page":"61","volume":"97","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Malaria vaccine: WHO position paper \u2013 march 2022. Wkly Epidemiol Rec. 2022;97(9):61\u201380.","journal-title":"Wkly Epidemiol Rec"},{"key":"5611_CR3","unstructured":"World Health Organization. Guide to introducing malaria vaccine into national immunization programmes. 2023. https:\/\/www.technet-21.org\/en\/topics\/programme-management\/malaria-vaccine. Accessed 23 September 2025."},{"key":"5611_CR4","unstructured":"Milligan P, Fogelson A. Statistical report, Malaria Vaccine Pilot Evaluation (MVPE), analysis of data to month 46. Geneva, World Health Organization, 2024. https:\/\/www.who.int\/publications\/m\/item\/statistical-report--malaria-vaccine-pilot-evaluation-(mvpe)--analysis-of-data-to-month-46"},{"key":"5611_CR5","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/S0140-6736(24)00004-7","volume":"403","author":"KP Asante","year":"2024","unstructured":"Asante KP, Mathanga DP, Milligan P, Akech S, Oduro A, Mwapasa V, et al. Feasibility, safety, and impact of the RTS,S\/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi. Lancet. 2024;403:1660\u201370.","journal-title":"Lancet"},{"key":"5611_CR6","first-page":"225","volume":"19","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Malaria vaccines: WHO position paper. Wkly Epidemiol Rec. 2024;19:225\u201348.","journal-title":"Wkly Epidemiol Rec"},{"key":"5611_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-021-01171-7","volume":"17","author":"M Klaic","year":"2022","unstructured":"Klaic M, Kapp S, Hudson P, Chapman W, Denehy L, Story D, et al. Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework. Implement Sci. 2022;17:10.","journal-title":"Implement Sci"},{"key":"5611_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.112513","volume":"280","author":"SJ Landes","year":"2019","unstructured":"Landes SJ, McBain SA, Curran GM. An introduction to effectiveness-implementation hybrid designs. Psychiatry Res. 2019;280:112513.","journal-title":"Psychiatry Res"},{"key":"5611_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/16094069231180162","volume":"22","author":"J Smith","year":"2023","unstructured":"Smith J, van der Groen O, Learmonth Y. Feasibility meets implementation science: narrowing the research-to-practice gap for exercise activity in multiple sclerosis. Int J Qual Methods. 2023;22:1\u201317.","journal-title":"Int J Qual Methods"},{"key":"5611_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-071188","volume":"13","author":"J Dusin","year":"2023","unstructured":"Dusin J, Melanson A, Mische-Lawson L. Evidence-based practice models and frameworks in the healthcare setting: a scoping review. BMJ Open. 2023;13:e071188.","journal-title":"BMJ Open"},{"key":"5611_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1365-2753.2000.00213.x","volume":"6","author":"RS Barbour","year":"2000","unstructured":"Barbour RS. The role of qualitative research in broadening the \u201cevidence base\u201d for clinical practice. J Eval Clin Pract. 2000;6:155\u201363.","journal-title":"J Eval Clin Pract"},{"key":"5611_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121801","volume":"11","author":"J Price","year":"2023","unstructured":"Price J, Gurley N, Gyapong M, Ansah EK, Awusabo-Asare K, Gyasi SF, et al. Acceptance of and adherence to a four-dose RTS,S\/AS01 schedule: findings from a longitudinal qualitative evaluation study for the malaria vaccine implementation programme. Vaccines. 2023;11:1801.","journal-title":"Vaccines"},{"key":"5611_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533\u201344.","journal-title":"Adm Policy Ment Health"},{"key":"5611_CR14","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1016\/S2214-109X(24)00013-5","volume":"12","author":"J Hill","year":"2024","unstructured":"Hill J, Bange T, Hoyt J, Kariuki S, Jalloh MF, Webster J, et al. Integration of the RTS,S\/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: a qualitative longitudinal study from the health system perspective. Lancet Glob Health. 2024;12:e672-E684.","journal-title":"Lancet Glob Health"},{"key":"5611_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12939-018-0841-x","volume":"17","author":"S Lewin","year":"2018","unstructured":"Lewin S, Glenton C. Are we entering a new era for qualitative research? Using qualitative evidence to support guidance and guideline development by the World Health Organization. Int J Equity Health. 2018;17:126.","journal-title":"Int J Equity Health"},{"key":"5611_CR16","unstructured":"World Health Organization. WHO recommends R21\/Matrix-M vaccine for malaria prevention in updated advice on immunization. 2023. https:\/\/www.who.int\/news\/item\/02-10-2023-who-recommends-r21-matrix-m-vaccine-for-malaria-prevention-in-updated-advice-on-immunization. Accessed 23 September 2025."},{"key":"5611_CR17","volume-title":"R21\/Matrix-M malaria vaccine: Evidence to recommendations framework","author":"WHO","year":"2023","unstructured":"WHO. R21\/Matrix-M malaria vaccine: Evidence to recommendations framework. Geneva: World Health Organization; 2023."},{"key":"5611_CR18","volume-title":"Full evidence report on the RTS, S\/AS01 malaria vaccine","author":"SAGE\/MPAG Working Group","year":"2022","unstructured":"SAGE\/MPAG Working Group. Full evidence report on the RTS, S\/AS01 malaria vaccine. Geneva: World Health Organization; 2022."},{"key":"5611_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12889-017-4320-x","volume":"17","author":"J Kaufman","year":"2017","unstructured":"Kaufman J, Ames H, Bosch-Capblanch X, Cartier Y, Cliff J, Glenton C, et al. The comprehensive \u2018Communicate to Vaccinate\u2019 taxonomy of communication interventions for childhood vaccination in routine and campaign contexts. BMC Public Health. 2017;17:423.","journal-title":"BMC Public Health"},{"key":"5611_CR20","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.1016\/j.vaccine.2020.09.017","volume":"38","author":"HM Scobie","year":"2020","unstructured":"Scobie HM, Edelstein M, Nicol E, Morice A, Rahimi N, MacDonald NE, et al. Improving the quality and use of immunization and surveillance data: summary report of the working group of the strategic advisory group of experts on immunization. Vaccine. 2020;38:7183\u201397.","journal-title":"Vaccine"},{"key":"5611_CR21","doi-asserted-by":"publisher","DOI":"10.2196\/28102","volume":"9","author":"I G\u00f6ttgens","year":"2021","unstructured":"G\u00f6ttgens I, Oertelt-Prigione S. The application of human-centered design approaches in health research and innovation: a narrative review of current practices. JMIR Mhealth Uhealth. 2021;9:e28102.","journal-title":"JMIR Mhealth Uhealth"},{"key":"5611_CR22","volume-title":"Risk communications on malaria vaccination: a guide","author":"WHO","year":"2023","unstructured":"WHO. Risk communications on malaria vaccination: a guide. Geneva: World Health Organization; 2023."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05611-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:18:36Z","timestamp":1763464716000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05611-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5611"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05611-3","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"408"}}